Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s):  SZLSF

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.


TSX:SZLS - Post by User

Bullboard Posts
Comment by TheDudeAbideson Jul 05, 2019 3:14pm
112 Views
Post# 29890629

RE:Opinion on SP when the news releases !

RE:Opinion on SP when the news releases !I think again it depends on how the agreement is structured, how profitable it is. The real hump here is Stage Zero to become self dependent financially. If they can find a way to turn a profit (as CEO metnions $30M by year end), I think .65 is not out of range. Without being profitable, it will always hold this company back from breaking out no matter what the news is. 

For me, I would rather a 2 or 3 cent increase weekly or bi weekly vs. 20 cents in a day only to have the stock give it back 2 or 3 days later (although I woudlnt turn away a .20 per share lift!). If Stage Zero can gain exposure through an agreement and we see some sustained higher volume, we should see a really nice return over time (based on our current SP).

If all the pieces fall into place, 2020 could be an amazing year for this company. This could only be the beginning!


Bullboard Posts